Nigel Stallard (N Stallard)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 21

Top Topics

Systematic Review

Amyotrophic Lateral Sclerosis

Top Venues

Biometrical journal. Biometrische Zeitschrift

The British journal of radiology

BMC medical research methodology

This page only lists publications with an associated author ORCID identifier.

Publications

Amin Yarahmadi, Lori E Dodd, Thomas F Jaki, Peter W Horby, Nigel Stallard
Group sequential designs for clinical trials when the maximum sample size is uncertain. Statistics in medicine (2024)
Karoline Freeman, Alice Mansbridge, Hilary Stobart, Karen Clements, Matthew G Wallis, Sarah E Pinder, Olive Kearins, Abeer M Shaaban, Cliona C Kirwan, Louise S Wilkinson, Sharon Webb, Emma O'Sullivan, Jacquie Jenkins, Suzanne Wright, Kathryn Taylor, Claire Bailey, Chris Holcombe, Lynda Wyld, Kim Edwards, David J Jenkinson, Nisha Sharma, Elena Provenzano, Bridget Hilton, Nigel Stallard, Alastair M Thompson, Sian Taylor-Phillips
Evidence-informed recommendations on managing breast screening atypia: perspectives from an expert panel consensus meeting reviewing results from the Sloane atypia project. The British journal of radiology 97 (1154) (2024)
Karoline Freeman, Alice Mansbridge, Hilary Stobart, Karen Clements, Matthew G Wallis, Sarah E Pinder, Olive Kearins, Abeer M Shaaban, Cliona C Kirwan, Louise S Wilkinson, Sharon Webb, Emma O'Sullivan, Jacquie Jenkins, Suzanne Wright, Kathryn Taylor, Claire Bailey, Chris Holcombe, Lynda Wyld, Kim Edwards, David J Jenkinson, Nisha Sharma, Elena Provenzano, Bridget Hilton, Nigel Stallard, Alastair M Thompson, Sian Taylor-Phillips
Evidence-informed recommendations on managing breast screening atypia: perspectives from an expert panel consensus meeting reviewing results from the Sloane atypia project. The British journal of radiology (2023)
Stella Jinran Zhan, Cornelia Ursula Kunz, Nigel Stallard
Should the two-trial paradigm still be the gold standard in drug assessment? Pharmaceutical statistics (2022)
Nigel Stallard
Adaptive enrichment designs with a continuous biomarker. Biometrics (2022)
Nigel Stallard
Rejoinder to discussion on "Adaptive enrichment designs with a continuous biomarker". Biometrics (2022)
Aaron Dane, John H Rex, Paul Newell, Nigel Stallard
The Value of the Information That Can Be Generated: Optimizing Study Design to Enable the Study of Treatments Addressing an Unmet Need for Rare Pathogens. Open forum infectious diseases 9 (7) (2022)
Charis Wong, Rachel S Dakin, Jill Williamson, Judith Newton, Michelle Steven, Shuna Colville, Maria Stavrou, Jenna M Gregory, Elizabeth Elliott, Arpan R Mehta, Jeremy Chataway, Robert J Swingler, Richard Anthony Parker, Christopher J Weir, Nigel Stallard, Mahesh K B Parmar, Malcolm Robert MacLeod, Suvankar Pal, Siddharthan Chandran
Motor Neuron Disease Systematic Multi-Arm Adaptive Randomised Trial (MND-SMART): a multi-arm, multi-stage, adaptive, platform, phase III randomised, double-blind, placebo-controlled trial of repurposed drugs in motor neuron disease. BMJ open 12 (7) (2022)
Daniel Gallacher, Nigel Stallard, Peter K Kimani, Elvan Gökalp, Juergen Branke
Development of a model to demonstrate the impact of National Institute of Health and Care Excellence cost-effectiveness assessment on health utility for targeted medicines. Health economics (2021)
Daniel Gallacher, Peter K Kimani, Nigel Stallard
Biased Survival Predictions When Appraising Health Technologies in Heterogeneous Populations. PharmacoEconomics (2021)
Charis Wong, Maria Stavrou, Elizabeth Elliott, Jenna M Gregory, Nigel Leigh, Ashwin A Pinto, Timothy L Williams, Jeremy Chataway, Robert Swingler, Mahesh K B Parmar, Nigel Stallard, Christopher J Weir, Richard A Parker, Amina Chaouch, Hisham Hamdalla, John Ealing, George Gorrie, Ian Morrison, Callum Duncan, Peter Connelly, Francisco Javier Carod-Artal, Richard Davenport, Pablo Garcia Reitboeck, Aleksandar Radunovic, Venkataramanan Srinivasan, Jenny Preston, Arpan R Mehta, Danielle Leighton, Stella Glasmacher, Emily Beswick, Jill Williamson, Amy Stenson, Christine Weaver, Judith Newton, Dawn Lyle, Rachel Dakin, Malcolm Robert MacLeod, Suvankar Pal, Siddharthan Chandran
Clinical trials in amyotrophic lateral sclerosis: a systematic review and perspective. Brain communications 3 (4) (2021)
Moreno Ursino, Nigel Stallard
Bayesian Approaches for Confirmatory Trials in Rare Diseases: Opportunities and Challenges. International journal of environmental research and public health 18 (3) (2021)
Ponnusamy Saravanan, Nithya Sukumar, Antonysunil Adaikalakoteswari, Ilona Goljan, Hema Venkataraman, Amitha Gopinath, Christos Bagias, Chittaranjan S Yajnik, Nigel Stallard, Yonas Ghebremichael-Weldeselassie, Caroline H D Fall
Association of maternal vitamin B12 and folate levels in early pregnancy with gestational diabetes: a prospective UK cohort study (PRiDE study). Diabetologia 64 (10) (2021)
Nigel Stallard, Susan Todd, Elizabeth G Ryan, Simon Gates
Comparison of Bayesian and frequentist group-sequential clinical trial designs. BMC medical research methodology 20 (1) (2020)
Tim Friede, Nigel Stallard, Nicholas Parsons
Adaptive seamless clinical trials using early outcomes for treatment or subgroup selection: Methods, simulation model and their implementation in R. Biometrical journal. Biometrische Zeitschrift 62 (5) (2020)
Karen L Barker, Meredith Newman, Nigel Stallard, Shelby D Reed, Catherine J Minns Lowe, Muhammad Kassim Javaid, Angela Noufaily, Anish Adhikari, Tamsin Hughes, David J Smith, Varsha Gandhi, Cyrus Cooper, Prof Sarah E Lamb
Exercise or manual physiotherapy compared with a single session of physiotherapy for osteoporotic vertebral fracture: three-arm PROVE RCT. Health technology assessment (Winchester, England) 23 (44) (2020)
Karen L Barker, Meredith Newman, Nigel Stallard, Shelby D Reed, Catherine J Minns Lowe, Muhammad Kassim Javaid, Angela Noufaily, Tamsin Hughes, David J Smith, Varsha Gandhi, Cyrus Cooper, Prof Sarah E Lamb, null null
Physiotherapy rehabilitation for osteoporotic vertebral fracture-a randomised controlled trial and economic evaluation (PROVE trial). Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 31 (2) (2019)
Nigel Stallard
Editorial for the Biometrical Journal Special Issue ISCB 2016. Biometrical journal. Biometrische Zeitschrift 60 (2) (2019)
Augustine Talumba Choko, Elizabeth Lucy Corbett, Nigel Stallard, Hendramoorthy Maheswaran, Aurelia Lepine, Cheryl C Johnson, Doreen Sakala, Thokozani Kalua, Moses Kelly Kumwenda, Richard J Hayes, Katherine Fielding
HIV self-testing alone or with additional interventions, including financial incentives, and linkage to care or prevention among male partners of antenatal care clinic attendees in Malawi: An adaptive multi-arm, multi-stage cluster randomised trial. PLoS medicine 16 (1) (2019)
Tim Friede, Martin Posch, Sarah Zohar, Corinne Alberti, Norbert Benda, Emmanuelle Comets, Simon Day, Alex Dmitrienko, Alexandra Graf, Burak Kürsad Günhan, Siew Wan Hee, Frederike Lentz, Jason Madan, Frank Miller, Thomas Ondra, Michael Pearce, Christian Röver, Artemis Toumazi, Steffen Unkel, Moreno Ursino, Gernot Wassmer, Nigel Stallard
Recent advances in methodology for clinical trials in small populations: the InSPiRe project. Orphanet journal of rare diseases 13 (1) (2018)
Michael Pearce, Siew Wan Hee, Jason Madan, Martin Posch, Simon Day, Frank Miller, Sarah Zohar, Nigel Stallard
Value of information methods to design a clinical trial in a small population to optimise a health economic utility function. BMC medical research methodology 18 (1) (2018)